Lynx1 Capital Management LP Portfolio Holdings
Lynx1 Capital Management LP
- $257 Million
- Q4 2024
Lynx1 Capital Management LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $257 Million distributed in 18 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $66.5M, Stoke Therapeutics, Inc. with a value of $57.2M, Gh Research PLC with a value of $34M, C4 Therapeutics, Inc. with a value of $24.7M, and Allogene Therapeutics, Inc. with a value of $23.2M.
Examining the 13F form we can see an decrease of $21.9M in the current position value, from $279M to 257M.
Lynx1 Capital Management LP is based out at San Juan, PR
Below you can find more details about Lynx1 Capital Management LP portfolio as well as his latest detailed transactions.